Newsroom

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, biopharma

Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomics to Compound Screening Scale

June 16, 2026

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

Alithea Genomics and Revvity announce distribution agreement to expand access to MERCURIUS™ DRUG-seq solutions

June 8, 2026

Categories: Biotechnology, General Laboratory

Safety without compromise: IKA launches the next evolution of magnetic stirring

May 19, 2026

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

NGI becomes first certified core lab and service provider for Epigenica’s EpiFinder™ platforms

May 19, 2026

Categories: Biomanufacturing, Biotechnology, Drug Discovery & Development

Cirena has entered into a licensing agreement with Agilent Technologies, Inc. for long RNA purification technology.

May 7, 2026

Categories: Biotechnology, Energy & Environment, Corporate, Finance & Investor

Takara Bio and Resistomap deepen collaboration to advance One Health AMR Surveillance with the SmartChip Biosecurity Platform

April 17, 2026

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

Plasmidsaurus accelerates RNA-Seq: New EU hub and Genovis partnership adds stability to speed, without the ice

April 2, 2026

Categories: Biotechnology, Clinical Research & Trials, Corporate, Finance & Investor

CellCarta secures global exclusivity for Biofidelity's Aspyre® Lung to advance targeted lung cancer testing

March 19, 2026

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

Epigenica AB Expands presence in Japan through distribution agreement with PrimeTech

March 19, 2026